| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Petros Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 40,000 | 21 Dec 2023 | Direct | ||
| Petros Pharmaceuticals, Inc. | Director | Common Stock | 8,314 | 26 Apr 2023 | Direct | ||
| Petros Pharmaceuticals, Inc. | Director | Restricted Stock Units | 0 | 26 Apr 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PTPI | Petros Pharmaceuticals, Inc. | 21 Dec 2023 | 1 | $0 | 4 | Director | 26 Dec 2023, 17:05 |
| PTPI | Petros Pharmaceuticals, Inc. | 26 Apr 2023 | 2 | $0 | 4 | Director | 28 Apr 2023, 18:03 |
| PTPI | Petros Pharmaceuticals, Inc. | 10 Apr 2023 | 1 | $0 | 4 | Director | 12 Apr 2023, 18:00 |
| PTPI | Petros Pharmaceuticals, Inc. | 20 Jan 2023 | 2 | $0 | 4 | Director | 25 Jan 2023, 15:16 |
| PTPI | Petros Pharmaceuticals, Inc. | 07 Apr 2022 | 1 | $0 | 4 | Director | 11 Apr 2022, 17:00 |
| PTPI | Petros Pharmaceuticals, Inc. | 22 Dec 2021 | 1 | $0 | 4 | Director | 07 Jan 2022, 15:44 |